Niva Bupa Share Price Rises 13.67% on May 8; PAT Soars 161% in FY25

Niva Bupa Health Insurance Company Limited has announced its financial results for the fourth quarter and the full fiscal year ended March 31, 2025.  

Post the announcement, on May 8, 2025, Niva Bupa share price opened at ₹87.03, up from its previous close of ₹81.03. At 9:58 AM, the share price of Niva Bupa was trading at ₹92.11, up by 13.67% on the NSE. 

Profit Growth and Premium Collection 

For FY25, Niva Bupa reported a Profit After Tax (PAT) of ₹214 crore, a sharp 161% jump from ₹82 crore in FY24. The company stated that this substantial increase underscores its improved operational efficiency and sustained business momentum. 

Gross Written Premium (GWP) also reflected growth. In Q4 FY25, the company recorded a GWP of ₹2,395 crore, up 36% YoY. For the entire fiscal year, GWP stood at ₹7,407 crore, registering a 32% increase from the previous year.  

When adjusted for the new IRDAI premium recognition framework (1/N accounting), Q4 GWP was ₹2,079 crore, up 18%, while FY25 adjusted GWP was ₹6,762 crore, showing a 21% rise over FY24. 

Regulatory Impact and Adaptation 

The IRDAI’s revised framework for premium recognition, effective from October 1, 2024, now requires long-term policy premiums to be recognised on an annual basis using the 1/N formula. Despite this change, Niva Bupa maintained a strong growth trajectory, demonstrating its adaptability and resilience in a dynamic regulatory environment. 

Operational Efficiency and Claims Excellence 

Niva Bupa made notable progress in improving operational metrics. Its Claims Settlement Ratio improved from 91.9% in FY24 to 92.4% in FY25, reflecting its commitment to providing a hassle-free claims experience. The Expense of Management was reduced from 39.3% to 37.4%, showcasing successful cost optimisation through automation and digitization across operations. 

Strengthened Financial Position 

The company’s solvency ratio improved significantly from 2.55 in FY24 to 3.03 in FY25, reinforcing its financial stability and ability to meet long-term obligations. This development aligns with Niva Bupa’s long-term strategic focus on maintaining a healthy financial position. 

Market Share Gains  

Niva Bupa increased its Retail Health Market Share from 9.1% to 9.4% YoY, reinforcing its status as a key player in India’s health insurance market.  

Commenting on the results, Krishnan Ramachandran, MD & CEO, Niva Bupa, said, “We are proud of the strong performance we have delivered this year, both in terms of top-line growth and customer service excellence. This growth is a testament to the trust customers place in us and our ability to deliver consistent value.”  

He further stated, “We continue to invest in building a strong and differentiated brand, digital transformation, and expanding our distribution channels to further strengthen our market presence and deliver superior healthcare protection to millions of Indians. Our focus remains on innovating for the customer, simplifying the claims process, and strengthening our digital backbone to drive further efficiencies and scalability.” 

Also Read: Why 40% of Non-Life Policyholders Struggle with Life Insurance? 

Conclusion 

Backed by fundamentals, technological innovation, and strategic clarity, the company is well-positioned to leverage India’s growing demand for health insurance in the years ahead. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.